Skip to main content
Top
Published in: Diabetologia 10/2017

01-10-2017 | Article

Proteomic characterisation reveals active Wnt-signalling by human multipotent stromal cells as a key regulator of beta cell survival and proliferation

Authors: Miljan Kuljanin, Gillian I. Bell, Stephen E. Sherman, Gilles A. Lajoie, David A. Hess

Published in: Diabetologia | Issue 10/2017

Login to get access

Abstract

Aims/hypothesis

Novel strategies to stimulate the expansion of beta cell mass in situ are warranted for diabetes therapy. The aim of this study was to elucidate the secretome of human bone marrow (BM)-derived multipotent stromal cells (MSCs) with documented islet regenerative paracrine function. We hypothesised that regenerative MSCs will secrete a unique combination of protein factors that augment islet regeneration.

Methods

Human BM-derived MSCs were examined for glucose-lowering capacity after transplantation into streptozotocin-treated NOD/severe combined immunodeficiency (SCID) mice and segregated into samples with regenerative (MSCR) vs nonregenerative (MSCNR) capacity. Secreted proteins associated with islet regenerative function were identified using stable isotope labelling with amino acids in cell culture (SILAC)-based quantitative proteomics. To functionally validate the importance of active Wnt signalling, we stimulated the Wnt-signalling pathway in MSCNR samples during ex vivo expansion using glycogen synthase kinase 3 (GSK3) inhibition (CHIR99201), and the conditioned culture media (CM) generated was tested for the capacity to support cultured human islet cell survival and proliferation in vitro.

Results

MSCR showed increased secretion of proteins associated with cell growth, matrix remodelling, immunosuppressive and proangiogenic properties. In contrast, MSCNR uniquely secreted proteins known to promote inflammation and negatively regulate angiogenesis. Most notably, MSCR maintained Wnt signalling via Wnt5A/B (~2.5-fold increase) autocrine activity during ex vivo culture, while MSCNR repressed Wnt signalling via Dickkopf-related protein (DKK)1 (~2.5-fold increase) and DKK3 secretion. Inhibition of GSK3 activity in MSCNR samples increased the accumulation of nuclear β-catenin and generated CM that augmented beta cell survival (13% increases) and proliferation when exposed to cultured human islets.

Conclusions/interpretation

Maintenance of active Wnt signalling within human MSCs promotes the secretion of matricellular and proangiogenic proteins that formulate a niche for islet regeneration.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060–2069CrossRefPubMed Ryan EA, Paty BW, Senior PA et al (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54:2060–2069CrossRefPubMed
3.
go back to reference Shapiro AMJ, Ryan EA, Lakey JRT (2001) Islet cell transplantation. Lancet 358:S214CrossRef Shapiro AMJ, Ryan EA, Lakey JRT (2001) Islet cell transplantation. Lancet 358:S214CrossRef
5.
go back to reference Pomeransky AA, Khriplovich IB (1999) Equations of motion of spinning relativistic particle in external fields. Surv High Energy Phys 14:145–173CrossRef Pomeransky AA, Khriplovich IB (1999) Equations of motion of spinning relativistic particle in external fields. Surv High Energy Phys 14:145–173CrossRef
6.
go back to reference Lee RH, Seo MJ, Reger RL et al (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci 103:17438–17443CrossRefPubMedPubMedCentral Lee RH, Seo MJ, Reger RL et al (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci 103:17438–17443CrossRefPubMedPubMedCentral
7.
go back to reference Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214–222CrossRefPubMed Lai RC, Arslan F, Lee MM et al (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214–222CrossRefPubMed
8.
go back to reference Anderson JD, Johansson HJ, Graham CS et al (2016) Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-Kappab signaling. Stem Cells 34:601–613CrossRefPubMed Anderson JD, Johansson HJ, Graham CS et al (2016) Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-Kappab signaling. Stem Cells 34:601–613CrossRefPubMed
9.
go back to reference Meyerrose T, Olson S, Pontow S et al (2010) Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 62:1167–1174CrossRefPubMed Meyerrose T, Olson S, Pontow S et al (2010) Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 62:1167–1174CrossRefPubMed
10.
go back to reference Madec AM, Mallone R, Afonso G et al (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52:1391–1399CrossRefPubMed Madec AM, Mallone R, Afonso G et al (2009) Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia 52:1391–1399CrossRefPubMed
11.
12.
go back to reference Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S (2007) Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25:2837–2844CrossRefPubMed Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S (2007) Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25:2837–2844CrossRefPubMed
13.
go back to reference Urbán VS, Kiss J, Kovács J et al (2008) Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26:244–253CrossRefPubMed Urbán VS, Kiss J, Kovács J et al (2008) Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26:244–253CrossRefPubMed
14.
go back to reference Bell GI, Broughton HC, Levac KD et al (2012a) Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev 21:97–109CrossRefPubMed Bell GI, Broughton HC, Levac KD et al (2012a) Transplanted human bone marrow progenitor subtypes stimulate endogenous islet regeneration and revascularization. Stem Cells Dev 21:97–109CrossRefPubMed
15.
go back to reference Bell GI, Meschino MT, Hughes-Large JM et al (2012b) Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors. Stem Cells Dev 21:1863–1876CrossRefPubMed Bell GI, Meschino MT, Hughes-Large JM et al (2012b) Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors. Stem Cells Dev 21:1863–1876CrossRefPubMed
16.
go back to reference Ong S-E (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376–386CrossRefPubMed Ong S-E (2002) Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics 1:376–386CrossRefPubMed
17.
go back to reference Bendall SC, Hughes C, Stewart MH et al (2008) Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol Cell Proteomics 7:1587–1597CrossRefPubMedPubMedCentral Bendall SC, Hughes C, Stewart MH et al (2008) Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol Cell Proteomics 7:1587–1597CrossRefPubMedPubMedCentral
18.
go back to reference Hess D, Li L, Martin M et al (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21:763–770CrossRefPubMed Hess D, Li L, Martin M et al (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21:763–770CrossRefPubMed
19.
go back to reference Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2:1097–1105CrossRefPubMedPubMedCentral Shibuya M (2011) Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2:1097–1105CrossRefPubMedPubMedCentral
20.
go back to reference Gordon MD, Nusse R (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433CrossRefPubMed Gordon MD, Nusse R (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433CrossRefPubMed
21.
go back to reference Yang Y (2003) Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130:1003–1015CrossRefPubMed Yang Y (2003) Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130:1003–1015CrossRefPubMed
22.
go back to reference Bakondi B, Shimada IS, Peterson BM, Spees JL (2011) SDF-1α secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7. Stem Cells Dev 20:1021–1029CrossRefPubMed Bakondi B, Shimada IS, Peterson BM, Spees JL (2011) SDF-1α secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7. Stem Cells Dev 20:1021–1029CrossRefPubMed
25.
go back to reference Cox J, Hein MY, Luber CA, Paron I (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell 13:2513–2526 Cox J, Hein MY, Luber CA, Paron I (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell 13:2513–2526
26.
go back to reference Rohani MG, Parks WC (2015) Matrix remodeling by MMPs during wound repair. Matrix Biol 44–46:113–121CrossRefPubMed Rohani MG, Parks WC (2015) Matrix remodeling by MMPs during wound repair. Matrix Biol 44–46:113–121CrossRefPubMed
27.
go back to reference Vadon-Le Goff S, Hulmes DJ, Moali C (2015) BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol 44–46:14–23CrossRefPubMed Vadon-Le Goff S, Hulmes DJ, Moali C (2015) BMP-1/tolloid-like proteinases synchronize matrix assembly with growth factor activation to promote morphogenesis and tissue remodeling. Matrix Biol 44–46:14–23CrossRefPubMed
28.
go back to reference Boomsma RA, Geenen DL (2012) Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One 7:e35685CrossRefPubMedPubMedCentral Boomsma RA, Geenen DL (2012) Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis. PLoS One 7:e35685CrossRefPubMedPubMedCentral
29.
go back to reference Ho TK, Tsui J, Xu S et al (2010) Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia. J Vasc Surg 51:689–699CrossRefPubMed Ho TK, Tsui J, Xu S et al (2010) Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia. J Vasc Surg 51:689–699CrossRefPubMed
30.
go back to reference Pepper MS (1996) Positive and negative regulation of angiogenesis: from cell biology to the clinic. Vasc Med 1:259–266CrossRefPubMed Pepper MS (1996) Positive and negative regulation of angiogenesis: from cell biology to the clinic. Vasc Med 1:259–266CrossRefPubMed
31.
go back to reference Blanpain C, Lowry WE, Pasolli HA, Fuchs E (2006) Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev 20:3022–3035CrossRefPubMedPubMedCentral Blanpain C, Lowry WE, Pasolli HA, Fuchs E (2006) Canonical notch signaling functions as a commitment switch in the epidermal lineage. Genes Dev 20:3022–3035CrossRefPubMedPubMedCentral
32.
go back to reference Yokoyama N, Yin D, Malbon CC (2007) Abundance, complexation, and trafficking of Wnt/β-catenin signaling elements in response to Wnt3a. J Mol Signal 2:11CrossRefPubMedPubMedCentral Yokoyama N, Yin D, Malbon CC (2007) Abundance, complexation, and trafficking of Wnt/β-catenin signaling elements in response to Wnt3a. J Mol Signal 2:11CrossRefPubMedPubMedCentral
33.
go back to reference Meijer L, Flajolet M, Greengard P (2004) Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25:471–480CrossRefPubMed Meijer L, Flajolet M, Greengard P (2004) Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol Sci 25:471–480CrossRefPubMed
34.
go back to reference Jin DK, Shido K, Kopp H et al (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12:557–567CrossRefPubMedPubMedCentral Jin DK, Shido K, Kopp H et al (2006) Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12:557–567CrossRefPubMedPubMedCentral
35.
go back to reference Brissova M, Shostak A, Shiota M et al (2006) Pancreatic islet production of vascular endothelial growth factor-A is essential for islet vascularization, revascularization, and function. Diabetes 55:2974–2985CrossRefPubMed Brissova M, Shostak A, Shiota M et al (2006) Pancreatic islet production of vascular endothelial growth factor-A is essential for islet vascularization, revascularization, and function. Diabetes 55:2974–2985CrossRefPubMed
36.
go back to reference Luo JZQ, Xiong F, Al-Homsi AS et al (2011) Human BM stem cells initiate angiogenesis in human islets in vitro. Bone Marrow Transplant 46:1128–1137CrossRefPubMed Luo JZQ, Xiong F, Al-Homsi AS et al (2011) Human BM stem cells initiate angiogenesis in human islets in vitro. Bone Marrow Transplant 46:1128–1137CrossRefPubMed
37.
go back to reference Blandino-Rosano M, Perez-Arana G, Mellado-Gil JM et al (2008) Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1. J Mol Endocrinol 41:35–44CrossRefPubMed Blandino-Rosano M, Perez-Arana G, Mellado-Gil JM et al (2008) Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide-1. J Mol Endocrinol 41:35–44CrossRefPubMed
38.
go back to reference Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219–226CrossRefPubMed Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5:219–226CrossRefPubMed
39.
40.
go back to reference Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA (2009) Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9:447–453CrossRefPubMedPubMedCentral Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA (2009) Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9:447–453CrossRefPubMedPubMedCentral
41.
go back to reference Yano T, Liu Z, Donovan J et al (2007) Stromal cell-derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt. Diabetes 56:2946–2957CrossRefPubMed Yano T, Liu Z, Donovan J et al (2007) Stromal cell-derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt. Diabetes 56:2946–2957CrossRefPubMed
42.
go back to reference Rooman I, Bouwens L (2004) Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57BI6/J mice treated with alloxan. Diabetologia 47:259–265CrossRefPubMed Rooman I, Bouwens L (2004) Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57BI6/J mice treated with alloxan. Diabetologia 47:259–265CrossRefPubMed
43.
go back to reference Hakonen E, Ustinov J, Mathijs I et al (2011) Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation. Diabetologia 54:1735–1743CrossRefPubMed Hakonen E, Ustinov J, Mathijs I et al (2011) Epidermal growth factor (EGF)-receptor signalling is needed for murine beta cell mass expansion in response to high-fat diet and pregnancy but not after pancreatic duct ligation. Diabetologia 54:1735–1743CrossRefPubMed
44.
go back to reference Zuo GW, Kohls CD, He BC et al (2010) The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol 25:795–806PubMedPubMedCentral Zuo GW, Kohls CD, He BC et al (2010) The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol 25:795–806PubMedPubMedCentral
45.
go back to reference Paradis R, Lazar N, Antinozzi P et al (2013) Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic β-cell function. PLoS One 8:1–8CrossRef Paradis R, Lazar N, Antinozzi P et al (2013) Nov/Ccn3, a novel transcriptional target of FoxO1, impairs pancreatic β-cell function. PLoS One 8:1–8CrossRef
46.
go back to reference Chowdhury S, Wang X, Srikant CB et al (2014) IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin. Endocrinology 155:1629–1642CrossRefPubMed Chowdhury S, Wang X, Srikant CB et al (2014) IGF-I stimulates CCN5/WISP2 gene expression in pancreatic β-cells, which promotes cell proliferation and survival against streptozotocin. Endocrinology 155:1629–1642CrossRefPubMed
47.
go back to reference Aly H, Rohatgi N, Marshall CA et al (2013) A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. PLoS One 8:e66131CrossRefPubMedPubMedCentral Aly H, Rohatgi N, Marshall CA et al (2013) A novel strategy to increase the proliferative potential of adult human β-cells while maintaining their differentiated phenotype. PLoS One 8:e66131CrossRefPubMedPubMedCentral
48.
go back to reference Figeac F, Uzan B, Faro M et al (2010) Neonatal growth and regeneration of -cells are regulated by the Wnt/ -catenin signaling in normal and diabetic rats. AJP Endocrinol Metab 298:E245–E256CrossRef Figeac F, Uzan B, Faro M et al (2010) Neonatal growth and regeneration of -cells are regulated by the Wnt/ -catenin signaling in normal and diabetic rats. AJP Endocrinol Metab 298:E245–E256CrossRef
49.
go back to reference Mussmann R, Geese M, Harder F et al (2007) Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. J Biol Chem 282:12030–12037CrossRefPubMed Mussmann R, Geese M, Harder F et al (2007) Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. J Biol Chem 282:12030–12037CrossRefPubMed
Metadata
Title
Proteomic characterisation reveals active Wnt-signalling by human multipotent stromal cells as a key regulator of beta cell survival and proliferation
Authors
Miljan Kuljanin
Gillian I. Bell
Stephen E. Sherman
Gilles A. Lajoie
David A. Hess
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4355-7

Other articles of this Issue 10/2017

Diabetologia 10/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.